Home › Funds › BVF INC/IL › TENX
BVF INC/IL position in TENX
TENAX THERAPEUTICS INC · Health Care
BVF INC/IL reported holding 339,549 shares of TENX (TENAX THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$4.9M, representing 0.13% of its reported portfolio and ranking #41 among its reported holdings. BVF INC/IL has disclosed TENX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BVF INC/IL's TENX position evolved
BVF INC/IL first disclosed a stake in TENX in Q3 2024 at 339,549 shares (US$1.2M). The position peaked in Q1 2026 at 339,549 shares, worth US$5.4M. Across 8 filings, BVF INC/IL held the position steady without any share-count change. The most recent filing (Q2 2026) shows 339,549 shares valued at US$4.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 339.55K | $1.17M | New |
| Q4 2024 | 339.55K | $2.10M | Hold |
| Q1 2025 | 339.55K | $2.22M | Hold |
| Q2 2025 | 339.55K | $1.98M | Hold |
| Q3 2025 | 339.55K | $2.58M | Hold |
| Q4 2025 | 339.55K | $4.14M | Hold |
| Q1 2026 | 339.55K | $5.43M | Hold |
| Q2 2026 | 339.55K | $4.94M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TENX and 13F data
TENX (TENAX THERAPEUTICS INC) is a Health Care company. 103 other funds we track also report a position in TENX — the largest reported positions include Vivo Capital, LLC (US$36.4M), Stonepine Capital Management, LLC (US$9.6M), Sofinnova Investments, Inc. (US$7.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TENX
- Vivo Capital, LLC 2.50M sh · $36.38M · Q2 2026
- Stonepine Capital Management, LLC 660.00K sh · $9.60M · Q2 2026
- Sofinnova Investments, Inc. 500.04K sh · $7.28M · Q2 2026
- DIADEMA PARTNERS LP 307.00K sh · $4.47M · Q2 2026
- Avidity Partners Management LP 265.93K sh · $3.87M · Q2 2026
- Verdad Advisers, LP 123.17K sh · $1.79M · Q2 2026
- Tetragon Partners GP Ltd 75.10K sh · $1.09M · Q2 2026
- Creek Drive Management Group LLC 74.00K sh · $1.08M · Q2 2026
- Velan Capital Investment Management LP 68.70K sh · $999.59K · Q2 2026
- Artia Global Partners LP 42.08K sh · $612.26K · Q2 2026
FAQ
How long has BVF INC/IL held TENX?
BVF INC/IL has disclosed TENX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.
What is BVF INC/IL's current position in TENX?
As of Q2 2026, BVF INC/IL holds 339.55K shares of TENX (TENAX THERAPEUTICS INC), valued at $4.94M, representing 0.13% of its reported portfolio and ranking #41.
Has BVF INC/IL been buying or selling TENX?
In the latest 13F filing (Q2 2026), BVF INC/IL held unchanged its position in TENX. The position peaked in Q1 2026 at 339.55K shares.
Which other funds hold TENX?
Other major institutional holders of TENX include Vivo Capital, LLC, Stonepine Capital Management, LLC, Sofinnova Investments, Inc., among 103 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.